
Arbutus Biopharma Corporation (ABUS)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more- Previous Close
4.2000 - Open
4.2000 - Bid 4.2800 x 1200
- Ask 4.3500 x 1200
- Day's Range
4.1650 - 4.3350 - 52 Week Range
2.9400 - 5.1000 - Volume
775,874 - Avg. Volume
2,427,425 - Market Cap (intraday)
849.795M - Beta (5Y Monthly) 0.74
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1700 - Earnings Date (est.) May 13, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
5.25
Recent News: ABUS
View MorePerformance Overview: ABUS
Trailing total returns as of 5/1/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends: ABUS
View MoreAnalyst Insights: ABUS
View MoreStatistics: ABUS
View MoreValuation Measures
-
Market Cap
827.15M
-
Enterprise Value
736.42M
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
57.14
-
Price/Book (mrq)
10.80
-
Enterprise Value/Revenue
52.29
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
-237.88%
-
Return on Assets (ttm)
-14.94%
-
Return on Equity (ttm)
-38.52%
-
Revenue (ttm)
14.08M
-
Net Income Avi to Common (ttm)
-33.5M
-
Diluted EPS (ttm)
-0.1700
Balance Sheet and Cash Flow
-
Total Cash (mrq)
91.47M
-
Total Debt/Equity (mrq)
5.47%
-
Levered Free Cash Flow (ttm)
-17.62M
Compare To: ABUS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.







